Personalized cancer vaccines may train the body’s immune system to fight tumors
A clinical trial at the University of Florida offers new hope for the future of cancer treatment. Researchers developed an mRNA vaccine that triggers the body’s immune system to attack brain tumors. While there’s still a long road ahead, Elias Sayour, professor for pediatric oncology research, is hopeful because early clinical trial results showed a rapid immune response in patients with glioblastoma, the most common form of brain cancer.
Sharing diverse perspectives on public health. Speakers do not speak for Harvard.
SUBSCRIBE to our YouTube channel @HarvardPublicHealth
If you love watching Harvard Chan Studio events like this one, subscribe to our newsletter: https://hsph.me/Studiosignup
Follow Harvard T.H. Chan School of Public Health
/ harvardpublichealth
/ harvardchansph
/ harvardpublichealth
/ harvardchanschool
https://www.threads.net/@harvardchansph
/ harvardchansph
